# Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid Tumors

> **NCT05586321** · PHASE1 · COMPLETED · sponsor: **Genmab** · enrollment: 26 (actual)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **BIOLOGICAL:** GEN1056

## Key facts

- **NCT ID:** NCT05586321
- **Lead sponsor:** Genmab
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-24
- **Primary completion:** 2025-10-23
- **Final completion:** 2025-10-23
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-11-24

## Collaborators

- BioNTech SE

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05586321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05586321, "Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05586321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*